- Home
- SLRN vs NUW Comparison
SLRN vs NUW Comparison
Compare SLRN & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- NUW
- Stock Information
- Founded
- SLRN 2020
- NUW 2008
- Country
- SLRN United States
- NUW United States
- Employees
- SLRN N/A
- NUW N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- NUW Investment Managers
- Sector
- SLRN Health Care
- NUW Finance
- Exchange
- SLRN Nasdaq
- NUW Nasdaq
- Market Cap
- SLRN 224.6M
- NUW N/A
- IPO Year
- SLRN 2023
- NUW N/A
- Fundamental
- Price
- SLRN $2.44
- NUW $13.71
- Analyst Decision
- SLRN Hold
- NUW
- Analyst Count
- SLRN 5
- NUW 0
- Target Price
- SLRN $9.60
- NUW N/A
- AVG Volume (30 Days)
- SLRN 731.5K
- NUW 45.3K
- Earning Date
- SLRN 05-16-2025
- NUW 01-01-0001
- Dividend Yield
- SLRN N/A
- NUW 3.66%
- EPS Growth
- SLRN N/A
- NUW N/A
- EPS
- SLRN N/A
- NUW N/A
- Revenue
- SLRN N/A
- NUW N/A
- Revenue This Year
- SLRN $267.11
- NUW N/A
- Revenue Next Year
- SLRN N/A
- NUW N/A
- P/E Ratio
- SLRN N/A
- NUW N/A
- Revenue Growth
- SLRN N/A
- NUW N/A
- 52 Week Low
- SLRN $1.85
- NUW $12.45
- 52 Week High
- SLRN $7.25
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- SLRN 53.86
- NUW 56.84
- Support Level
- SLRN $2.34
- NUW $13.43
- Resistance Level
- SLRN $2.64
- NUW $13.85
- Average True Range (ATR)
- SLRN 0.16
- NUW 0.17
- MACD
- SLRN 0.02
- NUW 0.03
- Stochastic Oscillator
- SLRN 67.83
- NUW 84.73
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.